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ABSTRACT
INTRODUCTION
Congenital pulmonary vein stenosis (PVS) is a rare condition, 
resulting from abnormal incorporation of the common pul-
monary vein into the left atrium.(1-3) One or more of the 4 
pulmonary veins may be involved and it is commonly associated 
with other congenital heart defects (CHD), but can occur in 
isolation.(2-4) Commonly, patients present with respiratory 
symptoms with varying degrees of pulmonary hypertension.(5,6) 
Surgical results are generally poor with a high risk of recurrence 
and high mortality.(3) Reports are limited to small case series 
with little data on outcomes.(7) The aim of the study was to 
describe a series of cases with congenital pulmonary vein 
stenosis seen at the Chris Hani Baragwanath Academic Hospital, 
a large Southern African tertiary institution, over a 25-year 
period.
METHODS AND SUBJECTS
Patients were retrospectively identified using an electronic 
paediatric cardiology database system dating from January 1990 
to January 2015. Clinical notes, catheterisation and imaging data 
of patients were reviewed. Data extracted for analysis included 
patient demographics, site of the lesion and the number of 
veins affected, associated congenital heart defects (CHD), and 
management strategies and outcomes. Patients with anomalous 
venous connection were excluded from this analysis.
Background: Congenital pulmonary vein stenosis (PVS) 
is a rare condition, which results from abnormal embry-
ological incorporation of the common pulmonary vein 
into the left atrium.
Methods: A retrospective descriptive case series study 
was conducted with the aim of describing the charac-
teristics and outcome of children with congenital PVS 
at an African tertiary care centre over a 25-year period. 
A computerised paediatric cardiology database initiated 
in the early 1990s was sourced to identify patients, 
following which clinical records were retrieved and 
reviewed. 
Results: Five cases of congenital PVS were identifi ed 
between January 1990 and January 2016 and accounted 
for 0.0007% of all congenital heart defects seen at the 
centre during the study period. The age at diagnosis 
ranged from 22 months - 13 years. Most patients 
presented with respiratory symptoms, with 2 patients 
presenting with recurrent haemoptysis. The diagnosis 
of PVS was confi rmed by cardiac catheterisation and 
pulmonary angiography in all patients. All cases were 
right-sided unilateral PVS and all were associated with 
one or more congenital heart defects. Mild pulmonary 
hypertension and elevated capillary wedge pressures 
were found in all patients. Only one patient underwent 
specifi c surgery to relieve the PVS, which subsequently 
recurred. Another patient underwent a lobectomy fol-
lowing recurrent haemoptysis, but subsequently died of 
sepsis. 
Conclusion: Congenital PVS is a rare condition often 
associated with other congenital cardiac defects. Respi-
ratory symptoms are common at presentation, with 
haemoptysis forming part of the presenting clinical 
spectrum, which is in keeping with the published 
literature. Elevated pulmonary artery pressures and 
increased ipsilateral pulmonary capillary wedge pressures 
are a common fi nding at catheterisation.
SAHeart 2019;16:318-323
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RESULTS
Five patients with congenital PVS were identif ied; congenital 
PVS accounted for 0.0007% of all CHD (5 out of 7 345 
cases) seen at our institution during the same time period. 
Three of the 5 patients were females and the age at diagnosis 
ranged from 22 months - 13 years. All cases of PVS were 
unilateral and right-sided and were associated with other 
CHD (Table 1).
Four of the 5 patients presented with respiratory distress, with 
one patient diagnosed incidentally during cardiac catheterisation 
undertaken to investigate the cause of pulmonary hypertension. 
The other presenting symptom was haemoptysis in 2 of the 5 
patients. All the patients had invasive cardiac catheterisation, 
which assisted in the diagnosis or confirmation of PVS. All were 
found to have pulmonary hypertension with mean pulmonary 
artery pressure (PAP) exceeding 25mmHg and all were also 
noted to have elevated pulmonary artery wedge pressures on 
the ipsilateral side of the PVS (Table 2). Of note, there was no 
elevation of oxygen saturations in the affected ipsilateral 
pulmonary artery, which can be associated with PVS as outlined 
in the discussion below. As part of management, all the patients 
underwent corrective surgery for the associated CHD.
Case 1 was referred for cardiac assessment at the age of 10 
months when she presented with shortness of breath and was 
noted to have a cardiac murmur. She underwent cardiac 
catheterisation for assessment of VSD and was found to have 
right upper and lower PVS. She had surgical closure of the 
VSD and widening of the pulmonary veins using a pericardial 
patch at the age of 12 months. She remained asymptomatic 
following the surgery but presented at the age of 10 years with 
respiratory distress and chest pain. She was found to have a 
double chamber right ventricle (DCRV), severe tricuspid 
regurgitation and recurrence of the PVS. She had surgery for 
resection of a right ventricle muscle bundle and repair of the 
tricuspid valve at the age of 12 years, with no further surgery 
on the pulmonary veins. At the age of 25 years, she remains 
asymptomatic in relation to the PVS.
Case 2 presented with respiratory distress and recurrent 
haemoptysis, and multimodality imaging with CT (Figure 1A and 
1B) and an X-ray pulmonary angiogram confirmed a diagnosis 
of right upper and lower PVS. Her associated CHD were a 
PDA and a discrete subaortic stenosis (DSAS), which were 
surgically managed. She underwent a right lower lobe lobectomy 
at the age of 22 months for a life threatening haemoptysis, 
but died a few days later from K. pneumoniae sepsis. The 
histology of the right lower lobe showed fresh alveolar haem-
orrhage and patchy oedema, with accumulation of intra-
parenchymal siderophages and a chronic inflammatory cell 
infiltrate. A small vessel resembling the pulmonary vein was 
identified, which had mild thickening of the media, thickened 
adventitial collagen and focal arterialisation. The pulmonary 
artery appeared abnormal with expansion of the intima by 
Case Age at diagnosis Sex
No. of 
veins 
affected
Side Presentation Other cardiac anomaly Surgery Outcome
1 10 months F 2 R Shortness of breath
VSD, DCRV
Severe TR
VSD closure
RV muscle bundle 
resection
TV repair
Widening of the 
pulmonary vein orifice
Recurrence of PVS
2 22 months F 2 R
Shortness of breath, 
haemoptysis
PDA, DSAS
PDA ligation,
DSAS Resection
Lobectomy
Died
3 6 years M 1 R
Recurrent chest 
infections
VSD, DSAS
VSD closure and 
DSAS resection
Lost to FU
4 10 years M 1 R
Pulmonary 
hypertension
TGV Atrial switch Lost to FU
5 13 years F 2 R
Haemoptysis, 
shortness of breath
ASD,
Cor triatriatum
ASD closure and 
resection of 
Cor triatriatum
Intermittent minor 
haemoptysis
TABLE 1: Patient characteristics.
ASD = trial septal defect, DSAS = discrete subaortic stenosis, DCRV = double chamber right ventricle, F = female, FU = follow-up, M = male, PDA = patent ductus arteriosus, 
R = right, VSD = ventricular septal defect, TB = tuberculosis, TGV = transposition of great vessels, TR = tricuspid regurgitation, TV = tricuspid valve.
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myofibroblasts and medial hypertrophy with prominent col-
lagenous adventitia. The arterioles were muscularised. The 
lymphatic vessels in the centrilobular areas, interlobular septae 
and pleura were ectatic.
Case 3 was referred for cardiac assessment at the age of 6 
years because of recurrent lower respiratory tract infections 
and a cardiac murmur. He underwent cardiac catheterisation 
for assessment of a VSD and a DSAS and was found to have 
right upper PVS. He remained asymptomatic after repair of 
the associated CHD and was subsequently lost to follow-up at 
the age of 13 years.
Case 4 was diagnosed with transposition of the great vessels 
(TGV) and had an atrial switch operation done at another 
hospital during the neonatal period. He was referred to our 
institution at 10 years of age for continued follow-up, where 
he was noted to have pulmonary hypertension on routine 
echocardiography. Cardiac catheterisation was performed to 
investigate the cause of the pulmonary hypertension and a 
pulmonary angiogram showed right upper PVS. This patient 
was subsequently lost to follow-up one year after the diagnosis 
of PVS, and was noted to be asymptomatic at the last clinic 
follow-up date.
Case 5 was diagnosed with cor triatriatum and an atrial septal 
defect (ASD), which was repaired at 12 months of age. She 
continued to be followed up post-operatively and presented 
with recurrent haemoptysis and respiratory distress at 13 years 
of age. A computerised tomography (CT) angiogram showed 
PVS, which was confirmed at invasive catheterisation (Figure 2A 
and 2B). At the age of 24 years, she continues to have recurrent 
episodes of minor haemoptysis and shortness of breath. She 
has had a successful pregnancy and has refused a lobectomy of 
the affected lung. 
DISCUSSION
We were able to identify 5 cases of congenital PVS over 25 
years at an African tertiary care centre, confirming the rarity of 
the condition.(1-3) A review of the literature has identified a 
small number of publications mostly in the form of case reports 
and small case series of congenital PVS.(3-7) The largest cohort 
of patients with congenital PVS published from one centre 
consisted of 31 patients identified over 20 years, with the 
incidence of congenital PVS among patients with congenital 
heart defects of 0.03% (31 of 98 126).(6)
Congenital PVS is thought to result from abnormal incorpora-
tion of the common pulmonary vein into the left atrium.(1-3) 
One or more of the 4 pulmonary veins may be involved, and 
may be unilateral on the left or right or bilateral and involve 
either lung.(1-5) All the cases of PVS in our study were unilateral 
and right sided, and only one or 2 pulmonary veins were 
Site
Pressures 
(mmHg)
Saturation 
(%)
Case 1 Case 2 Case 3 Case 4 Case 5
RV
41/0/6
82%
62/0/10
49/0/4
70%
38/0/4
72%
40/0/15
80%
MPA 40/20/27 38/15/33
49/11/29
77%
40/13/28
74%
38/20/29
74%
RPA
41/14/28
88%
37/11/23
45/10/28
77%
36/15/25
74%
42/20/28
76%
LPA 35/17/26 32/11/21
49/12/30
77%
37/14/25
74%
42/18/28
75%
RPW M=22 M=11 M=23 M=40 M=19
LPW M=14 M=12 M=10 M=15
LV 115/0/12 44/0/4
94/0/6
92%
110/0/5
91%
120/0/15
97%
AAO
66/34/50
100%
62/31/42
92/54/70
92%
110/78/90
91%
120/80/100
96%
TABLE I1: Haemodynamic data in patients with pulmonary vein stenosis.
Pressures recorded as systolic/mean/diastolic. AAO = ascending aorta, LPA = left pulmonary artery, LPW = left pulmonary wedge, LV = left ventricle, M = mean, 
MPA = main pulmonary artery, RPA = right pulmonary artery, RPW = right pulmonary wedge.
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involved. In contrast, Kingston, et al. reported 3 cases of 
unilateral left-sided PVS at the Royal Manchester Children’s 
Hospital in the United Kingdom. Furthermore, it has been 
observed that patients with unilateral PVS can progress to 
bilateral involvement.(6) 
The clinical presentation of patients in this study is comparable 
to previously reported case series where patients usually 
present with recurrent pulmonary symptoms, including 
haemoptysis.(2-5) The age at diagnosis, however, differed from 
other case series, with 4 of our patients being diagnosed at a 
relatively older age, after 3 years. Most patients with congenital 
PVS are documented to present in the first few months to 
years of life.(2,5,7) The timing and severity of symptoms is 
dependent on the number of pulmonary veins stenosed and 
the severity of the obstruction in each individual vein, with 
poor outcomes occurring in those with 3 or 4 pulmonary veins 
involved.(2,3) Breinholt et al. noted that patients with stenosis of 
only one or 2 pulmonary veins manifested with symptoms at 
an older age,(8) which may be the reason for the later pre-
sentation and diagnosis in our patients – all of whom had 
involvement of 1 - 2 pulmonary veins (Table 1). Congenital 
PVS is caused by a progressive neoproliferative process and 
may not be present at birth.(2,3) It is also possible that the study 
patients have a more benign disease process, which progresses 
more slowly, and hence the late presentation and diagnosis. 
The incidence of associated congenital heart defects in patients 
with congenital PVS ranges from 30% - 80%.(2,3) We have 
reported a higher incidence of associated CHDs with 100% of 
our patients having one or more associated CHDs. 
All patients were found to have mildly elevated pulmonary 
artery pressures, associated with markedly increased pulmonary 
capillary wedge pressures on the affected side (Table 2). The 
unilateral nature of the disease may explain the mild elevation 
of pulmonary artery pressures, because the unaffected con-
tralateral side provides a channel for decompression of ele-
vated pulmonary pressures.(3) As a result of decreased pul-
monary blood flow on the affected side, the pulmonary artery 
may become hypoplastic and systemic collateral arteries to 
that side can develop.(3,6) The systemic collateral arterial flow 
into the hypoplastic pulmonary artery on the affected side 
contributes to the raised pulmonary artery wedge pressure, 
and also to the higher pulmonary artery oxygen saturations 
reported in some patients with unilateral PVS.(3) Although 
hypoplastic right pulmonary arteries were present in patients 
2 and 5 (Table 1), the latter physiological feature was not 
observed.
PVS is associated with significant morbidity and mortality, with 
a less than 50% 5-year survival.(3,7,8) Although the small cohort 
of 5 patients, and the high level of loss to follow-up limit our 
FIGURE 1A CT angiogram and FIGURE 1B CT reconstruction: From case 2 showing 2 left pulmonary veins connecting to the 
left atrium (star). 
On the right, the pulmonary veins are not seen, with smooth left atrial wall at the expected location of the right pulmonary veins. There are 
pulmonary parenchymal changes on the right (Figure 1B). 
A
RV
LV
LA
LA
DAo
*
*
RA
B
DAo = descending aorta, LA = left atrium, LV = left ventricle, R = right, RA =  right atrium, RV = right ventricle, RPA = right pulmonary artery, PV = pulmonary vein.
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study, documented outcomes were poor. Only 2 patients 
underwent treatment for their PVS. One patient died from 
K. pneumoniae sepsis following a lobectomy on the side of 
the PVS for recurrent haemoptysis, while the other patient had 
PVS recurrence following surgical repair. One patient (case 5) 
has been followed up for 11 years since the diagnosis and at 
the age of 24 years continues to have recurrent episodes of 
minor haemoptysis and shortness of breath, and has refused 
further surgery.
Various treatment strategies, both surgical and transcatheter, 
have been employed in the treatment of pulmonary vein 
stenosis. Only 2 patients received interventions for their PVS 
in the study cohort – 1 of whom (case 1) had a pulmonary 
vein widening with a pericardial patch. Conventional surgical 
strategies include endarterectomy (excision of the stenotic ring 
and direct anastomosis of the PV to LA endocardium) and 
pericardial patch venoplasty (resection of the stenotic tissue 
and patch anastomosis to enlarge the tightened segment).(1,9,10) 
A new surgical strategy called sutureless marsupialisation 
where the pericardium surrounding the affected PV is directly 
attached to the LA, so direct stiches over the cut edges of 
the vessel are avoided, has been used.(9-11) Pneumonectomy 
such as in case 2, may be necessary for patients with haemop-
tysis, while those with unrelenting progression and develop-
ment of severe pulmonary hypertension, are managed with lung 
transplantation.(2,10) Overall, surgical outcomes have been 
disappointing. The condition is generally unresponsive to 
treatment and tends to recur.(4,7,10) Transcatheter interventions 
include the use of stents and balloon dilatation.(2,10,11) There are, 
however, poor outcomes with these interventions and limited 
experience of percutaneous interventions in children.(2,10,12) 
A recent study by Callahan, et al. explored the use of adjunct 
targeted biologic inhibition agents to treat paediatric PVS.(13) 
Histologic series have identified fibroblasts and myofibroblast-
like cells as significant contributors to the mesenchymal pro-
liferation that is a hallmark of pulmonary vein stenosis patho-
physiology.(2,14) Callahan, et al. evaluated the use of imatinib 
mesylate with or without bevacizumab targeting neoprolifera-
tive myofibroblast-like cells with tyrosine kinase receptor 
expression, as adjuncts to modern interventional therapies for 
the treatment of multivessel intraluminal pulmonary vein 
stenosis.(13) The results of the study were inconclusive with a 
major confounding factor being the use of other conventional 
management of the PVS during the study period. The role of 
these agents needs further evaluation. 
CONCLUSION
This is first case series report of congenital PVS in an African 
setting. We have confirmed that congenital PVS is a rare 
condition and that all cases were associated with other 
FIGURE 2A: The venous phase of a selective angiogram of the distal right pulmonary artery in Case 5 showing 2 pulmonary 
veins draining into a common vein, which has a discrete stenosis (arrow) at entry into the left atrium. 
FIGURE 2B: Main pulmonary artery angiogram from case 5 showing a relatively small right pulmonary artery (RPA), as 
compared to left pulmonary artery (LPA). 
A
RPA
LPA
B
RPA = right pulmonary artery, LPA = left pulmonary artery.
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congenital cardiac defects. Haemoptysis and respiratory signs 
are part of the presenting clinical spectrum, in keeping with 
the published literature. Our study patients presented late and 
may have had a less progressive disease. Variable increases in 
pulmonary artery pressures and markedly increased capillary 
wedge pressures were documented on the affected side. In 
view of the association with other CHD, we recommend that 
pulmonary vein interrogation be included in patients with 
CHD, particularly those presenting with haemoptysis, unilateral 
parenchymal lung changes and elevated pulmonary wedge 
pressures during routine imaging of the heart.
Conflict of interest: none declared.
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